Advocates fear New York state could be taking a step back when it comes to biomarker testing access for those with Medicaid.

A group of cancer survivors from the Bronx and statewide gathered outside Gov. Kathy Hochul’s NYC office on Third Avenue on ...

Biomarker testing has the potential to streamline diagnosis, treatment planning, and anticipation of treatment risks, if done right.

Gov. Kathy Hochul’s Executive Budget would weaken the evidence-based standards in New York’s biomarker testing law, putting ...

Researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove ...

A bill requiring state-run insurance plans to pay for biomarker testing passed committee in an 8-1 vote today at the ...

A Tennessee bill that would require health insurance and TennCare to cover biomarker testing, which gives doctors more ...

A newly FDA-approved therapy is offering a different approach for patients with platinum-resistant ovarian cancer—an area ...

Cancer survivors convened on Beacon Hill late last month to deliver emotional testimony alongside advocates and lawmakers, urging passage of bills to expand access to biomarker testing and patient ...

DNADX high scores predicted improved PFS, supporting genomic instability and DNA repair deficiency as biologically relevant ...